# Norepinephrine

Drug · id `cardio:norepinephrine` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Norepinephrine bitartrate; Levophed

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Acute care and long-term living  

## In plain language

Norepinephrine is a medicine given into a vein. The US label for the brand LEVOPHED lists it to raise blood pressure in adults with severe, acute hypotension (very low blood pressure that starts suddenly). The label calls it a catecholamine and says it narrows blood vessels and stimulates the heart. The body also makes norepinephrine as a nerve-signal chemical.

## Technical summary

RxNorm ingredient 7512; UNII IFY5PE3ZRW is the UNII of the salt, norepinephrine bitartrate, that the label gives, so it is a broad match; MeSH descriptor D009638 (Norepinephrine). US drug-label class: Catecholamine (established pharmacologic class, RxClass). The label read is the Hospira label for LEVOPHED, application NDA007513, effective 2025-06-12 in openFDA; other makers and premixed products sold under other applications were not read. The label does not name shock in the indication sentences read. This page records the label indication and the class only: no trial result and no dose is given. The parent class page (inotropes and vasopressors) is not written yet, so the page has no parent link. No condition page for hypotension exists yet, so the page has no condition link.

## Claims, with the population each applies to

## Context: Adults for whom the US LEVOPHED label lists raising blood pressure: severe, acute hypotension or acute hypotensive states

Recipient: Adult; Population: Adult patients with severe, acute hypotension or acute hypotensive states, as the indications section describes them.; Care setting: Intravenous medicine (route in the openFDA record: intravenous); Geography: United States (label of the US Food and Drug Administration); Life stage: Adults, as the label states; Follow-up: Not applicable (label statement)

### The US label of LEVOPHED (norepinephrine bitartrate, Hospira, NDA007513; version dated 12 June 2025 in openFDA) lists it to raise blood pressure in adult patients with severe, acute hypotension. The label calls it a catecholamine for restoring blood pressure in adults with acute hypotensive states.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Adult; Population: Adult patients with severe, acute hypotension or acute hypotensive states, as the indications section describes them.; Care setting: Intravenous medicine (route in the openFDA record: intravenous); Geography: United States (label of the US Food and Drug Administration); Life stage: Adults, as the label states; Follow-up: Not applicable (label statement)
- Limitations: This claim records what one label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded. The label does not name cardiogenic shock or septic shock in the sentences read. Only the indications section and the mechanism sentence were read; warnings, doses and adverse reactions were not recorded. Other makers and a premixed product are sold under other applications, which were not read. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.
- Last checked: 2026-11-08
- Sources:
  1. Supports: openFDA drug label record: LEVOPHED norepinephrine bitartrate (Hospira, NDA007513) (Label, edition openFDA drug label record, label effective 20250612, dataset last updated 2026-11-06.) <https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4de72a8-2a75-4984-ce90-e4870226dc12>
     Locator: results\[0\].openfda.application\_number\[0\]. Retrieved 2026-11-08T20:38:19Z. Source state: Current. Version fingerprint: 50eef227839336a5ca244131ecd96bd330e7874d989cff9fec2a7903d7b9cfa6.
     How it applies: Quoted at this locator.
  2. Supports: openFDA drug label record: LEVOPHED norepinephrine bitartrate (Hospira, NDA007513) (Label, edition openFDA drug label record, label effective 20250612, dataset last updated 2026-11-06.) <https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4de72a8-2a75-4984-ce90-e4870226dc12>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-08T20:38:19Z. Source state: Current. Version fingerprint: 50eef227839336a5ca244131ecd96bd330e7874d989cff9fec2a7903d7b9cfa6.
     How it applies: Quoted at this locator.
  3. Supports: openFDA drug label record: LEVOPHED norepinephrine bitartrate (Hospira, NDA007513) (Label, edition openFDA drug label record, label effective 20250612, dataset last updated 2026-11-06.) <https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4de72a8-2a75-4984-ce90-e4870226dc12>
     Locator: results\[0\].openfda.brand\_name\[0\]. Retrieved 2026-11-08T20:38:19Z. Source state: Current. Version fingerprint: 50eef227839336a5ca244131ecd96bd330e7874d989cff9fec2a7903d7b9cfa6.
     How it applies: Quoted at this locator.
  4. Supports: openFDA drug label record: LEVOPHED norepinephrine bitartrate (Hospira, NDA007513) (Label, edition openFDA drug label record, label effective 20250612, dataset last updated 2026-11-06.) <https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4de72a8-2a75-4984-ce90-e4870226dc12>
     Locator: results\[0\].indications\_and\_usage\[0\], 1 sentence 1. Retrieved 2026-11-08T20:38:19Z. Source state: Current. Version fingerprint: 50eef227839336a5ca244131ecd96bd330e7874d989cff9fec2a7903d7b9cfa6.
     How it applies: Quoted at this locator.
  5. Supports: openFDA drug label record: LEVOPHED norepinephrine bitartrate (Hospira, NDA007513) (Label, edition openFDA drug label record, label effective 20250612, dataset last updated 2026-11-06.) <https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4de72a8-2a75-4984-ce90-e4870226dc12>
     Locator: results\[0\].indications\_and\_usage\[0\], 1 sentence 2. Retrieved 2026-11-08T20:38:19Z. Source state: Current. Version fingerprint: 50eef227839336a5ca244131ecd96bd330e7874d989cff9fec2a7903d7b9cfa6.
     How it applies: Quoted at this locator.

## Connected pages

- Filed under this front: Medicines (`cardio:front-medicines`)
- The US label calls norepinephrine a peripheral vasoconstrictor and an inotropic stimulator of the heart: Inotropes and vasopressors (`cardio:inotropes-and-vasopressors`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 5 registry products
- 1 registry trial

## Provenance

Content hash: 74725163653b687216927c6f6e8e430166f94bf4ba7fc12852f06d071170c75c
Last substantive edit: 2026-11-08
Evidence last checked: 2026-11-08
